COAs are published on our COA page rather than supplied only on request, because purity should be documented, not asserted
A 2.5 mg track has short direct data and real-world support for stable maintainers, but continuing tirzepatide has much stronger evidence than stopping. At week 112, stepping down to 5 mg preserved 16.6% weight loss versus 21.9% on the top dose and 9.9% on placebo
Research Applications & Usage Information BPC-157 (15 mg) is generally used in laboratory research for: Studies of cellular signaling and communication , with a focus on peptide-mediated signaling changes
BPC-157 has also been suggested to stimulate blood flow, modulate nitric oxide levels, and support the healing of stomach ulcers and intestinal injuries
In rare cases, B12 injections can cause more serious side effects
While occasional moderate consumption probably does not negate treatment benefits entirely, heavy drinking during active healing protocols undermines the process